ACS
ALNY icon

Archford Capital Strategies’s Alnylam Pharmaceuticals ALNY Stock Holding History

Archford Capital Strategies’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$674K Buy
2,036
+12
+0.6% +$4.08K 0.08% 205
2025
Q4 		$805K Hold
2,024
– – 0.09% 182
2025
Q3 		$923K Buy
2,024
+7
+0.3% +$2.85K 0.11% 174
2025
Q2 		$658K Sell
2,017
-2
-0.1% -$553 0.08% 194
2025
Q1 		$545K Buy
+2,019
New +$519K 0.08% 196
2023
Q1 		– Sell
-1,041
Closed -$247K – 277
2022
Q4 		$247K Sell
1,041
-3
-0.3% -$640 0.06% 248
2022
Q3 		$209K Buy
+1,044
New +$199K 0.05% 261

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return